Company · INDV
Indivior Pharmaceuticals, Inc.
INDV is not in Nasdaq's symbol directory of securities listed on US exchanges.
In the 12 months to Nov 19, 2026: insiders bought on 2 occasions ($108K); insiders sold on 1 occasion ($765K); 2 filings by holders of 5% or more.
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Heidbreder Christian, Chief Scientific Officer sold $765K
- Anderson Woodrow D, Chief Accounting Officer bought $108K
Every trade (3)
- BUYAnderson Woodrow D, Chief Accounting Officer bought $54K
- BUYAnderson Woodrow D, Chief Accounting Officer bought $54K
- SELLHeidbreder Christian, Chief Scientific Officer sold $765K
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- Millennium Management LLC 5.4%
- Oaktree Capital Holdings, LLC 0.32%
Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.